FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200116463> ?p ?o ?g. }

• W4200116463 endingPage "6175" @default.
• W4200116463 startingPage "6175" @default.
• W4200116463 abstract "The development of drug resistance remains one of the greatest clinical oncology challenges that can radically dampen the prospect of achieving complete and durable tumour control. Efforts to mitigate drug resistance are therefore of utmost importance, and nanotechnology is rapidly emerging for its potential to overcome such issues. Studies have showcased the ability of nanomedicines to bypass drug efflux pumps, counteract immune suppression, serve as radioenhancers, correct metabolic disturbances and elicit numerous other effects that collectively alleviate various mechanisms of tumour resistance. Much of this progress can be attributed to the remarkable benefits that nanoparticles offer as drug delivery vehicles, such as improvements in pharmacokinetics, protection against degradation and spatiotemporally controlled release kinetics. These attributes provide scope for precision targeting of drugs to tumours that can enhance sensitivity to treatment and have formed the basis for the successful clinical translation of multiple nanoformulations to date. In this review, we focus on the longstanding reputation of pancreatic cancer as one of the most difficult-to-treat malignancies where resistance plays a dominant role in therapy failure. We outline the mechanisms that contribute to the treatment-refractory nature of these tumours, and how they may be effectively addressed by harnessing the unique capabilities of nanomedicines. Moreover, we include a brief perspective on the likely future direction of nanotechnology in pancreatic cancer, discussing how efforts to develop multidrug formulations will guide the field further towards a therapeutic solution for these highly intractable tumours." @default.
• W4200116463 created "2021-12-31" @default.
• W4200116463 creator A5005209374 @default.
• W4200116463 creator A5026101201 @default.
• W4200116463 creator A5081626069 @default.
• W4200116463 date "2021-12-07" @default.
• W4200116463 modified "2023-10-14" @default.
• W4200116463 title "Nanomedicine in Pancreatic Cancer: Current Status and Future Opportunities for Overcoming Therapy Resistance" @default.
• W4200116463 cites W1173721300 @default.
• W4200116463 cites W1568106481 @default.
• W4200116463 cites W1825341184 @default.
• W4200116463 cites W1843302206 @default.
• W4200116463 cites W1874889006 @default.
• W4200116463 cites W1924352148 @default.
• W4200116463 cites W1963987641 @default.
• W4200116463 cites W1965958391 @default.
• W4200116463 cites W1968323734 @default.
• W4200116463 cites W1971298987 @default.
• W4200116463 cites W1975088956 @default.
• W4200116463 cites W1975153720 @default.
• W4200116463 cites W1995592923 @default.
• W4200116463 cites W1996912024 @default.
• W4200116463 cites W1997392356 @default.
• W4200116463 cites W2003474213 @default.
• W4200116463 cites W2009749738 @default.
• W4200116463 cites W2013270956 @default.
• W4200116463 cites W2037995511 @default.
• W4200116463 cites W2051665875 @default.
• W4200116463 cites W2052617606 @default.
• W4200116463 cites W2057053889 @default.
• W4200116463 cites W2057256078 @default.
• W4200116463 cites W2059857576 @default.
• W4200116463 cites W2062029885 @default.
• W4200116463 cites W2064797051 @default.
• W4200116463 cites W2064862565 @default.
• W4200116463 cites W2066718759 @default.
• W4200116463 cites W2086834665 @default.
• W4200116463 cites W2088110734 @default.
• W4200116463 cites W2094820979 @default.
• W4200116463 cites W2109553089 @default.
• W4200116463 cites W2116183504 @default.
• W4200116463 cites W2117569814 @default.
• W4200116463 cites W2118524916 @default.
• W4200116463 cites W2127410754 @default.
• W4200116463 cites W2131025996 @default.
• W4200116463 cites W2131555383 @default.
• W4200116463 cites W2137357003 @default.
• W4200116463 cites W2144824249 @default.
• W4200116463 cites W2145859409 @default.
• W4200116463 cites W2151467658 @default.
• W4200116463 cites W2152389587 @default.
• W4200116463 cites W2153771870 @default.
• W4200116463 cites W2155703416 @default.
• W4200116463 cites W2164193797 @default.
• W4200116463 cites W2165480504 @default.
• W4200116463 cites W2170726961 @default.
• W4200116463 cites W2175185830 @default.
• W4200116463 cites W2175275937 @default.
• W4200116463 cites W2187036920 @default.
• W4200116463 cites W2187917981 @default.
• W4200116463 cites W2192943385 @default.
• W4200116463 cites W2217833765 @default.
• W4200116463 cites W2252306308 @default.
• W4200116463 cites W2256387072 @default.
• W4200116463 cites W2267425796 @default.
• W4200116463 cites W2270388924 @default.
• W4200116463 cites W2293645537 @default.
• W4200116463 cites W2314883044 @default.
• W4200116463 cites W2315191920 @default.
• W4200116463 cites W2335076883 @default.
• W4200116463 cites W2365311494 @default.
• W4200116463 cites W2401870987 @default.
• W4200116463 cites W2409932367 @default.
• W4200116463 cites W2436942341 @default.
• W4200116463 cites W2441336171 @default.
• W4200116463 cites W2443247373 @default.
• W4200116463 cites W2463131100 @default.
• W4200116463 cites W2466477633 @default.
• W4200116463 cites W2468690265 @default.
• W4200116463 cites W2469608959 @default.
• W4200116463 cites W2508070837 @default.
• W4200116463 cites W2510654794 @default.
• W4200116463 cites W2510960450 @default.
• W4200116463 cites W2514722279 @default.
• W4200116463 cites W2515129893 @default.
• W4200116463 cites W2518317305 @default.
• W4200116463 cites W2518520946 @default.
• W4200116463 cites W2519470903 @default.
• W4200116463 cites W2520601585 @default.
• W4200116463 cites W2529888383 @default.
• W4200116463 cites W2534459204 @default.
• W4200116463 cites W2534599288 @default.
• W4200116463 cites W2554773181 @default.
• W4200116463 cites W2555883270 @default.
• W4200116463 cites W2557783305 @default.
• W4200116463 cites W2559942094 @default.
• W4200116463 cites W2561259078 @default.
• W4200116463 cites W2561583042 @default.

• next